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Kopito, Ron R. Biosynthesis and Degradation of CFTR. Physiol. Rev. 79, Suppl.: S167-S173, 1999.-Many of the mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that cause cystic fibrosis interfere with the folding and biosynthetic processing of nascent CFTR molecules in the endoplasmic reticulum. Mutations in the cytoplasmic nucleotide binding domains, including the common allele DF508, decrease the efficiency of CFTR folding, reduce the probability of its dissociation from molecular chaperones, and largely prevent its maturation through the secretory pathway to the plasma membrane. These mutant CFTR molecules are rapidly degraded by cytoplasmic proteasomes by a process that requires covalent modification by multiubiquitination. The effects of temperature and chemical chaperones on the intracellular processing of mutant CFTR molecules suggest that strategies aimed at increasing the folding yield of this protein in vivo may eventually lead to the development of novel therapies for cystic fibrosis.
I. INTRODUCTION
The human CFTR gene encodes an integral membrane glycoprotein composed of 1,440 amino acid residues (26) . Sequence analysis indicates that CFTR is a The autosomal recessive human genetic disorder cysmember of the ''traffic ATPase'' or ABC transporter supertic fibrosis (CF) is caused by the loss or dysfunction of a family (11, 12) . Alignment of the CFTR sequence with plasma membrane Cl 0 channel known as the CF transother members of this family suggests the existence of membrane conductance regulator (CFTR) (15, 26, 28) . Alfive distinct structural domains: two membrane-spanning though the number of disease-associated sequence alterdomains (MSD), each composed of six membrane-spanations at the CFTR locus now exceeds 400, a single allele ning helices; two nucleotide-binding domains (NBD); and accounts for nearly 70% of CF chromosomes (15) . DF508 one central regulatory ''R domain.'' Although basic asis associated with a severe form of the disease; ú90% of pects of CFTR transmembrane topology have been con-CF patients have at least one DF508 allele. The subject firmed by biochemical analysis, the model remains necesof intensive scrutiny, the DF508 allele encodes an unstasarily crude in the absence of any detailed structural inforble and inefficiently folded CFTR polypeptide that fails to mation. Two essential features of CFTR structure are of be delivered to its proper cellular location in the plasma particular note for the discussions that follow. The bulk membrane. The investigation of the mechanisms that unof the amino acid residues that comprise the NBD and R derlie the biosynthesis, trafficking, and degradation of domain are predicted to be exposed to the cytoplasmic DF508 CFTR provides a unique opportunity to understand face of cellular membranes; aside from the ''loops'' that the pathogenesis of this genetic disease at the molecular and cellular level and is the subject of the present review. intervene between transmembrane helices 1 and 2 in S168 MSD1 and between 7 and 8 in the corresponding position cell periphery in cells stably or transiently transfected with wild-type CFTR (2) . In contrast, immunoreactivity in MSD2, very little of the mass of CFTR is likely to be exposed to the luminal or exofacial surface of cellular was restricted to a perinuclear ER-like distribution in cells expressing DF508. Kartner et al. (14) used monoclonal membranes.
anti-CFTR antibodies to examine CFTR expression in frozen sections of human sweat glands from normal and CF II. BIOGENESIS OF WILD-TYPE AND MUTANT skin biopsies. They observed a strong signal in the apical CYSTIC FIBROSIS TRANSMEMBRANE plasma membrane region of sweat ducts from normal do-CONDUCTANCE REGULATOR nors, consistent with physiological studies of transepithelial Cl 0 transport. In contrast, only weak signals were On SDS-PAGE gels, ''mature'' CFTR endogenously ex-detected in duct cells from DF508 homozygotes; those pressed in colonic cell lines like T84 migrates as a diffuse signals were restricted to an apparent ''cytoplasmic and band of 150-160 kDa, which has been referred to as ''band perinuclear'' location and were absent from the plasma C'' (2). The CFTR sequence contains two potential Asn-membrane region. Yang et al. (39) used electron microslinked oligosaccharide chains (at positions 894 and 900). copy coupled with immunoperoxidase staining to localize Pulse-chase analysis indicates that CFTR is initially syn-CFTR in cell lines transformed with recombinant adenovithesized as a 135-to 140-kDa core-glycosylated precursor rus vectors, confirming a peripheral distribution for wildcontaining high-mannose oligosaccharide chains that are type CFTR. Their data also confirmed that DF508 CFTR distinguishable by their sensitivity to endoglycosidase H was localized to the ER region. However, because of the (endoH) (2, 18, 35) . Thus, like other integral membrane diffusion typical of the immunoperoxidase product, preglycoproteins, the initial stages of CFTR biogenesis begin cise localization of CFTR to a specific membrane strucwith the formation in the endoplasmic reticulum (ER) ture or to a particular face of the ER or plasma membrane membrane of a core-glycosylated 135-to 140-kDa ''imma-was not possible in those studies. Clearly, a thorough ture'' form that is a precursor to the mature 150-to 160-electron microscopic study of CFTR localization in tissue kDa CFTR that contains complex, endoH-resistant oligo-and cells expressing mutant and wild-type proteins, using saccharide chains. Sometimes this mature form bearing a more precise reporter such as colloidal gold, would help complex glycans is designated ''fully glycosylated.'' To to resolve some important issues regarding the cell biolavoid confusion, the term mature CFTR in this review ogy of CFTR. refers specifically to CFTR that migrates as a diffuse, 150-to 160-kDa band (equivalent to band C; Ref. 2) that is resistant to digestion with endoH and thus presumed to B. Inefficient Intracellular Maturation have matured at least to the cis/medial cisternae of the of CFTR Precursors Golgi apparatus. The term immature CFTR specifically refers to the 135-to 140-kDa, endoH-sensitive form (equivThe absence of DF508 from the cell surface could be alent to band B; Ref. 2), corresponding to nascent CFTR due either to defective intracellular delivery or maturation that has not been processed by mannosidases in the cis/ of the protein to the plasma membrane, or to instability medial Golgi. The existence of other bands, including an of the mature DF508 protein at the cell surface. Pulseapparently unglycosylated form (band A; Ref. 2), compli-chase studies have been performed to discriminate becates this analysis and is discussed in section IIID. tween these two possibilities. Although both forms of CFTR are synthesized as initially indistinguishable 140-kDa immature core-glycosylated precursors, only wild-A. Mislocalization of DF508 CFTR type CFTR is chased to a Ç160-kDa, endoH-resistant mature form (18, 35) . These results suggest that deletion of The initial suggestion that CFTR ''mislocalization'' contributes to the pathogenesis of CF was provided by Phe-508 interferes with a step in the maturation of immature CFTR from the ER to the Golgi complex. This step Cheng et al. (2), who observed that COS cells transiently transfected with DF508 fail to accumulate immunoreac-is normally accompanied by the acquisition of complex N-linked oligosaccharide chains and is an important tive CFTR corresponding to the size of mature CFTR. In contrast, both the mature and the immature forms of checkpoint in the quality control pathway that operates in eukaryotic cells to prevent the deployment of improperly CFTR accumulate in COS cells transfected with wild-type CFTR. This steady-state distribution of CFTR in trans-folded membrane and secretory glycoproteins (for review, see Ref. 8) . Interestingly, maturation of wild-type CFTR fected cells has been confirmed in different cell lines by other laboratories (18, 35) and is also reflected in the is also inefficient. Less than 30% of newly synthesized 140-kDa immature CFTR molecules ever acquire complex pattern of immunoreactivity observed by light microscopy of transfected cells and human tissues. For example, oligosaccharides indicative of maturation to post-ER compartments, even in cells expressing low levels of endoge-CFTR antibodies detected immunoreactive protein at the S169 nous CFTR (18, 35) . Therefore, this inefficiency in CFTR amount of labeled DF508 associated with HSP70 was observed to decrease in parallel with the disappearance and maturation is not likely to be the consequence of overexpression, as originally suggested by Cheng et al. (2) . It is probable degradation (see sect. IIIB) of the mutant protein during the chase period. Although the site(s) of HSP70-possible that CFTR is inefficiently processed because of the absence of a limiting subunit or assembly factor. How-CFTR interaction with CFTR or DF508 have not been identified, it is reasonable to speculate that HSP70 interever, mature CFTR appears to be monomeric (19) . Moreover, processing efficiency is low even in polarized epithe-acts with cytoplasmically exposed portions, most likely the cytoplasmic loops and the NBD. Significantly, many lial cell lines that express endogenous CFTR and should also express additional putative interacting proteins. Pos-CF-associated mutations, including DF508, map to the putatively cytoplasmic portions of CFTR (see sect. IIIC). sibly, this low efficiency in CFTR processing is a consequence of the protein's expression in transformed, immorNascent CFTR also interacts with the transmembrane ER chaperone calnexin (23). This chaperone is unusual talized cell lines such as HEK 293 or COS. Maturation of CFTR has never been examined in native tissue or in in that its selectivity for newly synthesized chains in the ER is mediated, at least in part, by its lectinlike binding primary cell culture. Interestingly, the efficiency of assembly of the pentameric nicotinic acetylcholine receptor, to monoglucosylated high-mannose oligosaccharides (10) .
Pulse-labeled immature CFTR was coimmunoprecipitated which approaches 100% in primary chick muscle cell culture (29) , is reduced to Ç20% in established muscle cell with calnexin from cells transfected with CFTR or DF508, and from epithelial cells expressing endogenous CFTR lines (21) or in transfected cells (6a) . Moreover, the inefficiency of acetylcholine receptor assembly in transfected (23). No mature CFTR bands were detected in calnexin coimmunoprecipitates, even after a prolonged chase, concells can be partially reversed by overexpression of the molecular chaperone calnexin (6a). On the other hand, the sistent with the hypothesis that calnexin is a chaperone that interacts only with incompletely folded, ER forms of maturation of P-glycoprotein, an ABC transporter bearing significant structural similarity to CFTR, is nearly 100% in nascent polypeptides. Thus, like HSP70, calnexin appears to interact transiently with newly synthesized forms of HEK 293 cells (Ref. 17; C. Ward and R. Kopito, unpublished data), indicating that inefficient processing is not a CFTR; dissociation of immature CFTR from calnexin is accompanied by its conversion to the mature form. universal property of transformed cell lines. These data underscore the need to characterize more fully the pathThese data suggest that at least two chaperones, HSP70 and calnexin, participate in CFTR biogenesis. Both way of CFTR folding and, in particular, the role of cellular assembly factors and chaperones in this process.
chaperones appear to form transient complexes with nascent, immature CFTR molecules. Dissociation of these complexes correlates temporally with the maturation of C. Immature CFTR Molecules Are Transiently CFTR molecules to a post-ER compartment and with a Associated With Molecular Chaperones large increase in the metabolic stability of CFTR molecules. It remains to be established, however, whether the two chaperones act sequentially or simultaneously during The folding of proteins, particularly oligomeric or multidomain proteins, occurs in cells in association with CFTR biogenesis.
A key unresolved question is how, or whether, these molecular chaperones (9, 20) . Transient interaction of nascent polypeptides with such chaperone molecules helps chaperone interactions contribute to the retention or degradation of misfolded CFTR (or DF508) chains in the ER. reduce the probability of inappropriate interaction of incomplete partially folded intermediates and increases the Both HSP70 and calnexin also interact with immature forms of DF508; the amount of DF508 associated with overall yield of correctly folded product. Molecular chaperones are present in all cellular compartments including either chaperone appears to decrease in parallel with the total amount of immature DF508 molecules. These data the ER. Yang et al. (39) reported that immature CFTR was immunoprecipitated from pulse-labeled cells with anti-have been interpreted to indicate that, compared with CFTR, the interaction of HSP70 with DF508 is ''probodies to cytoplasmic 70-kDa heat shock protein (HSP70), but not with antibodies against the ER chaperone BiP longed.'' However, to determine whether these chaperones have a role in targeting misfolded DF508 molecules (39) . The apparent lack of association of CFTR with BiP may reflect the fact that little of CFTR's mass is likely to for degradation, it would be important to determine whether the chaperones dissociate from misfolded chains be accessible to the ER lumen or that BiP association may be fleeting. No association was detected between HSP70 before degradation. Although previous studies have established a correlation between the amount of chaperoneand the mature form of CFTR (after chase), suggesting that the interaction with HSP70 is transient and is specific associated, pulse-labeled DF508 and the total amount of DF508 in cells, they have not directly addressed the quesfor newly synthesized, core-glycosylated chains. Likewise, immature DF508 was also present in HSP70 immunopre-tion of whether all immature DF508 is chaperone associated. For example, future studies might assess whether cipitates from cells expressing the mutant construct. The S170 the fraction of DF508 that is not associated with chaper-rected from plasma membrane to ER in sweat duct cells from DF508 homozygotes (as is implicit in designating ones changes during a chase.
How can the ''quality control'' machinery discrimi-DF508 a ''trafficking'' mutation) but is reduced to nearly undetectable levels (14) . What little immunoreactive nate between misfolded CFTR molecules and those that are in the process of folding? Are there other chaperones DF508 there is in the ER of mutant cells probably represents molecules that have yet to be degraded; thus it is that participate in folding and degradation of CFTR? Pulse-chase and coimmunoprecipitation studies suggest possible to produce the appearance of ER retention by overexpressing DF508 to levels that exceed the capacity that at least two ER luminal chaperones, BiP and GRP94, do not interact detectably with either DF508 or CFTR. of the cells to degrade the protein.
However, the participation of other chaperones, including those of the TRiC, HSP90, HSP40, and low-molecularweight families, may also contribute to CFTR maturation; B. DF508 Produces a Conditional Block in Folding investigation of these interactions may provide answers of NBD1 to some of the questions posed above.
III. DEGRADATION OF CYSTIC FIBROSIS
Overexpression of DF508 cDNA in mammalian cells TRANSMEMBRANE CONDUCTANCE leads to the appearance of functional CFTR Cl 0 channels REGULATOR in the plasma membrane (4), suggesting that the DF508 mutation is ''leaky.'' Because most people afflicted with CF have at least one copy of DF508, the observation of A. Immature CFTR Is Rapidly Degraded residual function in DF508 CFTR raises the possibility of developing a therapeutic strategy based on remediation The data presented above suggest the following of the DF508 phenotype. In principle, this leakiness could model: CFTR and DF508 are synthesized in the rough ER result if one or more components of the quality control as immature core-glycosylated 140-kDa precursors, which apparatus were saturated due to overexpression (a massare associated with cytoplasmic HSP70 and calnexin. A action effect), or if some small proportion of nascent fraction (20-40%) of CFTR matures to the Golgi appara-DF508 molecules was able to fold correctly, thereby estus, coincident with its dissociation from HSP70 and calcaping degradation (a kinetic effect). Several lines of evinexin and with its conversion to a stable (half-life Å 7.5 dence argue in favor of the kinetic model. First, DF508 h) Ç160-kDa form bearing endoH-resistant complex type molecules can be detected at the cell surface of Xenopus oligosaccharides. The majority (60-80%) of immature oocytes (6) or mammalian cells (5) when cultured at re-CFTR and nearly all immature DF508 molecules fail to duced (20-30ЊC) temperature, suggesting that the block mature and are quantitatively and rapidly (half-life Å 20-in maturation is temperature sensitive. Second, DF508 40 min) degraded. Thus maturation of CFTR precursor maturation can be increased by treating cells with high from ER to Golgi is accompanied by an Ç20-fold increase concentrations of glycerol, a small membrane-permeant in stability. Inhibiting ER-to-Golgi traffic with brefeldin A polyol that can function as a ''chemical chaperone'' in prevents the formation of the high-molecular-weight stabilizing protein structure (1, 31) . Third, studies of the CFTR species (18, 35) . Under these conditions, a fraction refolding of denatured, isolated, bacterial-expressed (20-40%) of immature-sized CFTR molecules neverthe-NBD1 in vitro suggest that the DF508 mutation stabilizes less becomes resistant to degradation, indicating that esa folding intermediate that is prone to self-aggregation cape from the ER is not a prerequisite for the increased (24, 25). Thus, although the yield of NBD1 refolding is stability characteristic of the mature protein. This stabilireduced by deletion of Phe-508, neither the kinetics of zation likely reflects the acquisition of a correct tertiary refolding nor the stability of the refolded protein is afstructure (see below) that is accompanied by chaperone fected by this mutation. Moreover, the refolding yield is release and, in the absence of brefeldin A, maturation increased both by reduced temperature and by the presto the Golgi apparatus. The DF508 mutation evidently ence of chemical chaperones like glycerol (24). These data interferes with this folding step. The DF508 molecules, suggest that the misprocessing phenotype of DF508 retherefore, remain in an unfolded or partially folded state, sults from a decrease in the efficiency of one or more are not correctly released from interaction with chapersteps in the NBD1 folding pathway, with consequent selfones, and are rapidly delivered to the degradation machinaggregation of nascent DF508 polypeptides. Whether the ery. It is not, strictly speaking, correct to assert that the particular kinetic step(s) that are affected by the DF508 DF508 mutation causes CFTR to be retained in the ER, mutation are the same as those that reduce the overall because ''retained'' implies a stability that is not normally efficiency in wild-type CFTR folding remains to be deterobserved. This view is also more consistent with the obmined. servation that CFTR immunoreactivity is not simply redi-S171
C. Misfolding of NBD1 and NBD2 Have D. Degradation of Misfolded CFTR by the Ubiquitin-Proteasome Pathway Nonequivalent Effects on CFTR Maturation
The ''misfolding'' phenotype is not restricted to the Several lines of evidence suggest that misfolded CFTR chains are substrates for the ubiquitin-proteasome DF508 allele, although DF508 is by far the most common disease-associated allele. Indeed, many missense pathway. Treatment of cells expressing CFTR or DF508 with proteasome inhibitors, including the reportedly spemutations in CFTR, either naturally occurring (CF associated) or produced through site-directed mutagenesis, cific drug lactacystin, causes the accumulation of multiubiquitinated forms of CFTR that can be detected as a appear to interfere with the maturation of nascent CFTR chains to the plasma membrane. These include characteristic 7-kDa ''ladder,'' suggesting that CFTR and DF508 degradation is mediated by the proteasome (36) . mutations in the MSD (34), the NBD (7), and the cytoplasmic loops (3, 32, 33) . Strikingly, as first noted by Moreover, in proteasome-inhibited cells, CFTR antibodies immunoprecipitate a high-molecular-weight ''smear'' that Gregory et al. (7), maturation of CFTR appears to be more sensitive to mutations in NBD1 than to mutations is recognized with antibodies to ubiquitin or to an epitope tag on ubiquitin, demonstrating that undegraded CFTR is at homologous positions in NBD2. For example, of 15 missense or deletion mutations in NBD1, only 3 result modified by ubiquitin (36) . Finally, CFTR-immunoreactive protein accumulates in cells in which multiubiquitination in a protein that is able to mature. In contrast, of 13 mutations in NBD2, only 1 has been reported to be mis-has been impaired by coexpression of dominant negative ubiquitin, demonstrating that multiubiquitination is not processed. This is all the more striking if one considers that of five homologous pairs of residues at the two only a consequence of the accumulation of undegraded CFTR, but is a prerequisite for its degradation (36) . Al-NBD, all at NBD2 are correctly processed and only one substitution at one NBD1 position is processed. Given though these data establish a role for the ubiquitin-proteasome pathway in CFTR and DF508 degradation, they do the degree of sequence homology between the CFTR NBD and NBD of other nucleotide hydrolyzing proteins, not exclude the possibility that other proteases may also participate in this process, either independent of or coopit is surprising that identical mutations at homologous positions in the two CFTR NBD have such different eratively with the proteasome.
Proteasomes are abundant in the cytoplasm and nuconsequences for the overall fate of the protein. One possibility for this discrepancy is that assumptions cleus of eukaryotic cells, where they mediate the degradation of ubiquitinated substrates. Although proteasomes based on structural similarity are incorrect, or that the folding pathways for these similar domains differ. This have been reported to be associated with the cytoplasmic surface of the ER membrane (22, 27), there is no evidence issue could be addressed by comparing the effect of mutations at parallel positions in NBD1 and NBD2 in for the presence of these proteolytic particles within the ER lumen. Because the bulk of CFTR's mass is predicted the in vitro refolding assay described above. Alternatively, this phenomenon could suggest that the quality to be exposed to the cytoplasm, extensive portions of CFTR are potentially accessible to degradation by memcontrol machinery is more tolerant of subtle mutations at the second NBD compared with the first NBD. This brane-associated proteasomes. However, roughly onethird of CFTR is predicted to be embedded in the lipid kind of discrimination might result if the commitment to degrade misfolded CFTR occurred early in its biosyn-bilayer. How can cytoplasmic proteasomes degrade these membrane-protected portions of CFTR? One possible thesis, possibly even cotranslationally, as the COOHterminal domain is synthesized immediately before re-mechanism, suggested initially by studies of rapid degradation of newly synthesized myosin heavy chain class I lease of CFTR from the ribosome. It is possible that release from the ribosome or from the translocation heavy chains (37, 38) , may involve dislocation of the translocated and membrane-integrated polypeptide from the apparatus serves as an early ''checkpoint'' in the quality control processes that monitor protein folding in the ER membrane. Several membrane and secretory proteins have now been shown to be degraded by cytoplasmic ER. Indeed, misfolded CFTR and DF508 molecules are degraded rapidly, without apparent lag after synthesis proteasomes after their dislocation to the cytoplasm and deglycosylation by cytoplasmic N-glycanases (16) . Inhibi- (35) . Moreover, at least in vitro, nascent CFTR polypeptides are multiubiquitinated cotranslationally, before re-tion of proteasome activity leads to the accumulation of deglycosylated species that are present in the cytosol or lease from the ribosome (30). Thus nascent CFTR chains that lack correctly folded NBD1 are more likely at the cytoplasmic side of microsomal vesicles. Although there is presently no direct evidence that such a mechato interact with components of the quality control apparatus before the completion of synthesis than are chains nism also participates in CFTR degradation by the proteasome, it should be noted that, in addition to the characterthat contain misfolded NBD2. Clearly, additional studies will be needed to resolve this puzzling and interest-istic smear of high-molecular-weight aggregated and ubiquitinated CFTR, inhibition of proteasome activity also ing observation.
leads to the accumulation of a detergent-insoluble form that proteasomes are sufficient for degradation of at least some ER degradation substrates. of CFTR that migrates at the size of the core protein lacking any N-linked glycans (band A) (36) , suggesting that deglycosylation of CFTR does accompany its degra-IV. PROSPECTS FOR CYSTIC dation by the proteasome. Further studies will be required FIBROSIS THERAPY to ascertain whether or not membrane dislocation is required for CFTR degradation. If CFTR is not dislocated,
The frequency of the DF508 allele among CF patients then it is difficult to imagine how proteasomes at the and the fact that Cl 0 channel activity is not disrupted by cytoplasmic face of the membrane can degrade all three loss of Phe-508 suggest the possibility of strategies for CF topological domains of this integral membrane protein.
treatment based on increasing the efficiency of folding and intracellular processing of this mutant. Loss of this E. Are Other Proteases Also Involved in ER amino acid decreases the efficiency of folding of NBD1 in Degradation of CFTR?
vitro and appears to increase the probability that nascent CFTR chains become committed to degradation by a pathway that involves at least in part the ubiquitin/proteasome The effects of proteasome inhibitors on CFTR degrapathway. It is unlikely that strategies based on inhibition dation have also been evaluated by pulse-chase analysis.
of intracellular proteases involved in CFTR degradation Interestingly, proteasome inhibitors have only a modest will be useful therapeutics, because blocking degradation effect on the half-life of CFTR and, despite a measurable only leads to accumulation of inactive, aggregated forms slowing of degradation (after Ç1-h chase), do not appear and has no detectable impact on DF508 maturation. Liketo block CFTR degradation completely (13, 18) . For examwise, the data suggest that the ubiquitin pathway is unple, even in the presence of proteasome inhibitors, nearly likely to be a productive target for therapy, since blocking all immature CFTR has disappeared after a 3-h chase.
ubiquitination leads to accumulation of aggregated CFTR These results have been interpreted by some to suggest and does not appear to increase DF508 maturation. These that proteasome inhibitors only retard, not block, CFTR results suggest that even though multiubiquitination of degradation, implying that additional nonproteasomal CFTR occurs early in CFTR biogenesis, perhaps cotranslaproteolytic systems also contribute to CFTR degradation tionally, it occurs after the nascent chains have become (13) . However, extensive screening of known protease committed to misfolding. Clearly, the development of inhibitors in combination with proteasome inhibitors has strategies aimed at increasing DF508 maturation will renot revealed any protease inhibitors that further stabilize quire a better understanding of the early steps in the fold-CFTR (Ward and Kopito, unpublished data). Several obing pathway. In particular, it will be important to characservations suggest that an alternative explanation must terize more fully the molecular chaperones and cellular also be considered. What is measured in these pulse-chase factors that interact with nascent CFTR molecules. An studies is typically the decay in radioactivity migrating at exciting prospect is the possibility that chemical chaperthe 140-to 150-kDa size corresponding to immature CFTR, ones, small, cell-permeant molecules like glycerol, can immunoprecipitated from nonionic detergent extracts of increase DF508 folding yield, possibly by stabilizing an labeled cells. Proteasome inhibitors clearly slow this deotherwise unstable folding intermediate. The challenge is cay. However, this decay does not reflect exclusively degformidable, however, as glycerol concentrations required radation. During the chase period, undegraded CFTR molfor detectable effect on DF508 maturation in vivo are in ecules gradually shift to a higher molecular weight smear excess of 1 M. Recently, Loo and Clarke (17) reported (13) and eventually become insoluble in nonionic deterthat misfolding and degradation of another ABC transgents (C. Ward, unpublished data). These changes in porter, the human P-glycoprotein, can be corrected in vivo CFTR mobility could be the result of both multiubiquitinawhen the protein is bound to transport substrates. The tion and aggregation, which would be expected if the hypossibility that small molecules will be able to interact drophobic MSD of this protein were dislocated to the specifically with and stabilize a particular CFTR (or cytosol. It is possible that the ''disappearance'' of CFTR DF508) folding intermediate, thereby promoting folding, over time may in fact be due to an increase in molecular is worthy of consideration. weight resulting from ubiquitination and aggregation. Thus it is exceedingly difficult to quantify the fraction of I am indebted to the members of my laboratory for their CFTR that is degraded and that which is shifted to sizes helpful critique of the manuscript and to Dr. Philip J. Thomas that may not even enter the SDS-PAGE gels used for the (Univ. of Texas) for sharing data before its publication. analyses. It is worth noting that proteasome inhibitors
